Navigate this market better. Subscribe for FREE stock alerts and information.

Wednesday, June 25, 2014

Valeant calls its shareholders to a special meeting, (NYSE: AGN), (NYSE: VRX), (TSE: VRX.TO)

Valeant Pharmaceuticals International on Wednesday said it had called a special meeting for its shareholders to approve the issuance of new shares, another step in its pursuit of Botox maker Allergan Inc . Valeant's multiple offers for Allergan have been rebuffed and the company is proceeding with a hostile takeover. It has taken its $53 billion offer, made jointly with Pershing Square Capital Management head William Ackman, directly to shareholders through a separate proxy solicitation to Allergan investors.

Allergan, Inc. is a multi-specialty health care Company focused on developing and commercializing pharmaceuticals, biologics, medical devices and over-the-counter products. Shares of AGN traded higher by 0.32% or $0.53/share to $165.35. In the past year, the shares have traded as low as $82.56 and as high as $172.48. On average, 4562160 shares of AGN exchange hands on a given day and today's volume is recorded at 1721319.

Valeant Pharmaceuticals International, Inc., formerly Biovail Corporation, is a multinational, specialty pharmaceutical company that develops, manufactures and markets a range of pharmaceutical products. Shares of VRX fell by 0.57% or $-0.69/share to $120.52. In the past year, the shares have traded as low as $84.36 and as high as $153.10. On average, 3635200 shares of VRX exchange hands on a given day and today's volume is recorded at 2201761.

Valeant Pharmaceuticals International, Inc., formerly Biovail Corporation, is a multinational, specialty pharmaceutical company that develops, manufactures and markets a range of pharmaceutical products. Shares of VRX fell by 0.5% or $-0.65/share to $129.41. In the past year, the shares have traded as low as $88.09 and as high as $170.45. On average, 398932 shares of VRX.TO exchange hands on a given day and today's volume is recorded at 372174.



Source